Integra Lifesciences Holdings Corp IART
News
-
Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm
-
Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference
-
Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference
-
Integra LifeSciences Continues to Make Progress on Its ESG Strategy
-
Integra LifeSciences Reports Second Quarter 2024 Financial Results
-
INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
-
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
-
Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
Trading Information
- Previous Close Price
- $16.95
- Day Range
- $16.96–17.47
- 52-Week Range
- $16.81–45.42
- Bid/Ask
- $16.82 / $17.27
- Market Cap
- $1.32 Bil
- Volume/Avg
- 686,510 / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 6.01
- Price/Sales
- 0.85
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 13.27%
Company Profile
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,946
- Website
- https://www.integralife.com
Comparables
Valuation
|
Metric
|
IART
|
CNMD
|
688016
|
|---|---|---|---|
Price/Earnings (Normalized) | 6.01 | 17.85 | 22.39 |
Price/Book Value | 0.86 | 2.33 | 3.46 |
Price/Sales | 0.85 | 1.64 | 9.68 |
Price/Cash Flow | 7.07 | 11.33 | 19.38 |
Price/Earnings
IART
CNMD
688016
Financial Strength
|
Metric
|
IART
|
CNMD
|
688016
|
|---|---|---|---|
Quick Ratio | 1.73 | 1.01 | 8.91 |
Current Ratio | 3.39 | 2.34 | 9.53 |
Interest Coverage | 1.13 | 4.20 | 413.50 |
Quick Ratio
IART
CNMD
688016
Profitability
|
Metric
|
IART
|
CNMD
|
688016
|
|---|---|---|---|
Return on Assets (Normalized) | 1.20% | 5.07% | 16.12% |
Return on Equity (Normalized) | 2.92% | 14.10% | 18.19% |
Return on Invested Capital (Normalized) | 2.39% | 8.09% | 17.54% |
Return on Assets
IART
CNMD
688016
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Fsrddpwv | Mhkmd | $196.0 Bil | |||
| Stryker Corp
SYK
| Wjfcgcbb | Gfvd | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Wcdrhvqk | Kcdgs | $124.5 Bil | |||
| Medtronic PLC
MDT
| Gynnpyd | Gnxhvr | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Vqfvkbyzcs | Dxpbrr | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Ynrf | Svwn | $30.2 Bil | |||
| DexCom Inc
DXCM
| Lxlxjrgps | Qmf | $27.3 Bil | |||
| Steris PLC
STE
| Jmhfjmbh | Crtgy | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Tgbqtlksb | Xlr | $21.3 Bil | |||
| Insulet Corp
PODD
| Hmgfnxbtqf | Dmxvlx | $16.1 Bil |
United States